SECHI, Leonardo Alberto
 Distribuzione geografica
Continente #
NA - Nord America 22.076
EU - Europa 6.708
AS - Asia 1.834
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 8
OC - Oceania 6
Totale 30.683
Nazione #
US - Stati Uniti d'America 21.913
UA - Ucraina 2.591
IT - Italia 1.156
DE - Germania 995
CN - Cina 992
FI - Finlandia 838
IE - Irlanda 435
SG - Singapore 412
SE - Svezia 325
TR - Turchia 251
CA - Canada 156
GB - Regno Unito 107
VN - Vietnam 67
BE - Belgio 57
RU - Federazione Russa 49
FR - Francia 40
IN - India 38
IR - Iran 31
CZ - Repubblica Ceca 29
EU - Europa 24
TG - Togo 23
NL - Olanda 20
AT - Austria 16
KR - Corea 15
ES - Italia 12
JP - Giappone 8
AU - Australia 6
TW - Taiwan 6
CH - Svizzera 4
CL - Cile 4
EE - Estonia 4
PL - Polonia 4
RO - Romania 4
RS - Serbia 4
IL - Israele 3
MX - Messico 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BT - Bhutan 2
HR - Croazia 2
ME - Montenegro 2
PE - Perù 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GL - Groenlandia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 30.683
Città #
Woodbridge 2.604
Fairfield 2.543
Jacksonville 1.859
Ann Arbor 1.741
Chandler 1.482
Houston 1.474
Ashburn 1.225
Wilmington 1.106
Dearborn 1.061
Seattle 980
Cambridge 886
Boardman 619
Princeton 469
Dublin 431
Beijing 415
Singapore 310
Izmir 247
Udine 187
San Diego 181
Ottawa 138
Des Moines 112
Ogden 101
Norwalk 91
Hefei 87
Nanjing 76
Milan 72
Kunming 69
San Mateo 68
Dong Ket 66
Falls Church 59
Brussels 48
Redmond 48
Rome 44
Helsinki 39
Trieste 39
Guangzhou 38
Grafing 31
New York 30
Jinan 24
Brno 23
Lomé 23
Munich 22
Washington 22
Nanchang 21
Leawood 18
Shanghai 18
Fuzhou 16
Indiana 16
Hebei 14
Saint Petersburg 14
Zanjan 14
Mcallen 13
Andover 12
Los Angeles 12
Vienna 12
Wuhan 12
Pignone 11
Toronto 11
Baotou 10
Bologna 10
Codroipo 10
Hangzhou 10
Phoenix 10
Henderson 9
Nanning 9
Tavagnacco 9
Turin 9
Xian 9
Augusta 8
Chongqing 8
Hyderabad 8
Shenyang 8
Simi Valley 8
Venezia 8
Vicenza 8
Bitetto 7
Lappeenranta 7
Taranto 7
Torre Del Greco 7
Zhengzhou 7
Cantu 6
Changsha 6
Chengdu 6
Dallas 6
Mumbai 6
Palermo 6
Paris 6
Pescara 6
Taipei 6
Verona 6
Wenzhou 6
Amsterdam 5
Ancona 5
Castellammare Di Stabia 5
Gorizia 5
Harbin 5
Porcia 5
Pune 5
Sacramento 5
Shaoxing 5
Totale 21.701
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 239
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 159
Primary aldosteronism: cardiovascular, renal and metabolic implications 152
Aldosterone and the heart: from basic research to clinical evidence 144
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 143
Methacrylates allergy in a professional beautician 139
Aldosterone and Left Ventricular Remodeling 139
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 136
Abnormalities of insulin receptors in spontaneously hypertensive rats 134
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 134
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 131
BLUNTED EFFECT OF ANP ON HEMATOCRIT AND PLASMA-VOLUME IN STREPTOZOTOCIN-INDUCED DIABETES-MELLITUS IN RATS 131
Venous thrombosis and acute renal failure in paroxysmal nocturnal haemoglobinuria. 130
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 127
SERUM-INSULIN, INSULIN SENSITIVITY, AND ERYTHROCYTE SODIUM-METABOLISM IN NORMOTENSIVE AND ESSENTIAL HYPERTENSIVE SUBJECTS WITH AND WITHOUT OVERWEIGHT 126
Aldosterone and the heart: still an unresolved issue? 125
Aldosterone, Organ Damage, and Dietary Salt 125
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 122
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 122
Nickel and sulfites food allergy in patients with angioedema associated with ACE inhibitor use 121
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 121
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 121
The emergent cardiovascular risk factors and organ damage in arterial hypertension 118
Intrahepatic cholestatis of pregnancy; a in vivo model of the hepatic clearance of adiponectin 117
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 117
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 117
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 116
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 116
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 115
Benzodiazepines: an old class of new antihypertensive drugs? 115
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 115
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II) 115
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 115
Treatment of primary aldosteronism and organ protection 115
Prohypertensive effect of insulin: possible role of the sympathetic system 114
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 114
Abnormalities of glucose metabolism in patients with early renal failure 114
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 114
Effects of alcohol withdrawal on blood pressure in hypertensive heavy drinkers 113
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 113
Kidney in primary aldosteronism: a key determinant of treatment outcome 112
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 112
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 112
Spontaneous restoration of sinus rhythm after cardiac surgery 111
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes 111
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 111
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 110
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 110
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS-C INFECTION WITH NO EVIDENCE OF LIVER-DISEASE 109
Benign familial macrocytosis 109
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 109
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 108
Salt, hypertension, and cardiovascular disease 108
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 108
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 108
Ontogenic expression of renal and hepatic angiotensin II receptor genes in the rat 107
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 107
Cardiovascular outcomes in patients with primary aldosteronism after treatment 107
Elevated serum CA 19-9 in hepatic actinomycosis 106
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 106
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 106
DISTRIBUTION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN RAT AND HUMAN KIDNEY 105
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial 105
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 105
ANTIHYPERTENSIVE EFFECT OF INSULIN REDUCTION IN DIABETIC-HYPERTENSIVE PATIENTS 104
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 103
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 103
Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects 102
Renal function in primary aldosteronism 102
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 102
Potassium-sparing diuretics in hypertension 102
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 102
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 102
The SPARTACUS Trial: Controversies and Unresolved Issues 102
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 102
Correlazioni clinico-prognostiche del diabete mellito in pazienti con arteriopatia degli arti inferiori sintomatica:dati preliminari 101
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 101
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 101
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance 101
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 101
CHARACTERIZATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT-KIDNEY AND HEART USING THE NONPEPTIDE ANTAGONISTS DUP-753 AND PD-123-177 100
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 100
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 100
THE CARDIAC RENIN-ANGIOTENSIN SYSTEM IN STZ-INDUCED DIABETES 99
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 99
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 99
URODILATIN BINDS TO AND ACTIVATES RENAL RECEPTORS FOR ATRIAL-NATRIURETIC-PEPTIDE 98
Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus 98
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 98
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 97
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 97
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. 97
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 96
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 95
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 95
EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS 94
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 94
Uricaemia and left ventricular mass in hypertensive patients 94
INSULINEMIA AND BLOOD-PRESSURE - RELATIONSHIPS IN PATIENTS WITH PRIMARY AND SECONDARY HYPERTENSION, AND WITH OR WITHOUT GLUCOSE-METABOLISM IMPAIRMENT 93
Glucose metabolism in early renal failure 93
Totale 11.263
Categoria #
all - tutte 115.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.311 0 0 0 1.139 579 1.527 963 1.032 543 706 178 644
2020/20215.176 147 556 166 674 162 681 240 604 892 182 624 248
2021/20223.594 136 421 153 263 100 149 201 212 55 585 692 627
2022/20233.748 539 211 75 421 328 1.103 14 238 520 76 112 111
2023/20241.229 185 92 94 56 234 129 38 32 152 67 20 130
2024/20251.069 171 619 248 31 0 0 0 0 0 0 0 0
Totale 31.714